Dermira, Inc.

ACTIVE

275 Middlefield Rd Ste 150, 加利福尼亚州圣马特奥县, California, United Stateswww.dermira.comPublic333 employeesEstablished: 2010-01-01

Part of Eli Lilly & Co.

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2010

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

58.8%

Phase 2

23.5%

Phase 3

17.6%

Trial Status Distribution

Active, not recruiting

41.2%

Completed

58.8%

Clinical Trials

Trials sponsored by this organization (17)

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Phase 1

Active, not recruiting

Oct 2020400 participants

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB WHEN USED IN COMBINATION WITH TOPICAL CORTICOSTEROID TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Phase 1

Active, not recruiting

Aug 2020225 participants

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Phase 1

Active, not recruiting

Feb 2020400 participants

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Phase 1

Active, not recruiting

Jan 2020400 participants

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Phase 1

Active, not recruiting

Jan 2020424 participants

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Phase 3

Completed

interventional

Mar 2017748 participants

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Phase 3

Completed

interventional

Feb 2017744 participants

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Phase 3

Completed

interventional

Dec 2016759 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations